Ralf A. Ledda serves as Senior Vice President, General Manager - Europe, Middle East and Africa of the Company. Previously he served for 21 years as Managing Director of Alber GmbH, Albstadt, Germany, Invacare's subsidiary that specializes in innovative electromotive technology and power add-on devices used with medical and recreational products. Mr. Ledda has a degree in industrial engineering from the University of Munich. Prior to joining Alber, Mr. Ledda worked at Siemens AG.
As the Senior Vice President、 General Manager - Europe、 Middle East and Africa of Invacare, the total compensation of Ralf Ledda at Invacare is 1,203,150$. There are 4 executives at Invacare getting paid more, with Matthew Monaghan having the highest compensation of 8,340,920$.
Ralf Ledda is 52, he's been the Senior Vice President、 General Manager - Europe、 Middle East and Africa of Invacare since 2016. There are 14 older and 2 younger executives at Invacare. The oldest executive at Invacare Corp. is Susan Alexander, 63, who is the Independent Director.
Ralf's mailing address filed with the SEC is ONE INVACARE WAY, , ELYRIA, OH, 44035.
Over the last 21 years, insiders at Invacare have traded over 3,551,958$ worth of Invacare stock and bought 391,450 units worth 2,325,949$ . The most active insiders traders include Edward F Crawford、Aaron Malachi Iii Mixon、Steven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of 10,700$. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth 47,900$.
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.
Invacare executives and other stock owners filed with the SEC include: